TROPION-Lung08: Phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC

Future Oncology, Ahead of Print.

Source: Future Oncology - May 30, 2023 Category: Cancer & Oncology Authors: Benjamin P Levy Enriqueta Felip Martin Reck James CH Yang Federico Cappuzzo Yasuto Yoneshima Caicun Zhou Siddhartha Rawat Jingdong Xie Priyanka Basak Lu Xu Jacob Sands Source Type: research